Towards Improved Diagnostics for Suspected Platelet Function Disorders
Trial statusRecruiting
Trial phaseNot listed
Trial typeObservational
Biological sexAll
Age12+
SponsorRegion Stockholm
About this trial
This study aims to improve platelet function testing during bleeding investigations. To this end, the study will evaluate the diagnostic accuracy of novel platelet function tests in patients with confirmed or suspected platelet function disorders. Study participants will be recruited from patients that are referred to or treated at the Coagulation Unit, Karolinska University Hospital, and Pediatric Coagulation Unit, Astrid Lingren Children's Hospital.
Eligibility criteria
Qualifiers
Known platelet function disorder under follow-up at Karolinska University Hospital (genetic or functional assay)
High likelihood of platelet function disorder (aberrant screening test with inheritance)
Family investigation for platelet disorder
Disqualifiers
Antiplatelet or anticoagulant drugs
vWF:GPIb below 0.40 IU/mL
Hematocrit below 0.35 or above 0.50
Other coagulation disorder
Trial design
Treatments tested in this trial
- Not listed
Trial groups
140 Participants
are grouped into 2 trial groupsSponsors and collaborators
Region Stockholm
Lead sponsor
Karolinska Institutet
Collaborator
Source ClinicalTrials.gov